Key Takeaways -
CMS proposes to significantly expand the use of virtual direct supervision for incident-to services, removing prior limitations based on Professional Component (PC)/Technical Component (TC) indicators and...more
The emergence of generative machine learning models, such as ChatGPT, has led to a surge in interest in artificial intelligence (“AI”) over the past year. This increased interest extends to the health care industry, where AI...more
12/6/2023
/ Artificial Intelligence ,
Health Information Technologies ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Healthcare ,
HITECH Act ,
Innovative Technology ,
Life Sciences ,
Machine Learning ,
New Guidance ,
OMB ,
Personally Identifiable Information ,
PHI
On October 6, 2023, the Drug Enforcement Agency (DEA) and the Department of Health and Human Services (HHS) issued a Second Temporary Rule, further extending the ability to prescribe controlled substances via telemedicine...more
10/12/2023
/ Controlled Substances ,
Coronavirus/COVID-19 ,
DEA ,
Electronic Prescribing ,
Health Care Providers ,
Healthcare ,
Patient Access ,
Pharmacies ,
Prescription Drugs ,
Public Health Emergency ,
Telehealth ,
Telemedicine ,
Temporary Regulations
Recent months have seen a heightened interest in artificial intelligence (“AI”)-based technology solutions. Although AI is derived from neural networks that date back to the 1940s, new technologies such as generative AI...more
5/11/2023
/ Artificial Intelligence ,
CEHRT ,
Digital Health ,
Health Care Providers ,
Health Information Technologies ,
Healthcare ,
Innovative Technology ,
Life Sciences ,
Popular ,
Proposed Rules ,
Regulatory Agenda
Two days ahead of the expiration of the COVID-19 Public Health Emergency (PHE), the Drug Enforcement Agency (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued a temporary rule extending...more
5/11/2023
/ Controlled Substances ,
Coronavirus/COVID-19 ,
DEA ,
Electronic Prescribing ,
Health Care Providers ,
Healthcare ,
Life Sciences ,
Patient Access ,
Prescription Drugs ,
Public Health Emergency ,
SAMHSA ,
Telehealth ,
Telemedicine
The Drug Enforcement Administration (DEA) is seeking approval from the White House to temporarily extend current COVID-19 Public Health Emergency (PHE) flexibilities for prescribing controlled substances via telemedicine....more
5/5/2023
/ Controlled Substances ,
DEA ,
Health Care Providers ,
Healthcare ,
OMB ,
Patient Access ,
Prescription Drugs ,
Public Health Emergency ,
Regulatory Agenda ,
Telehealth ,
Telemedicine
On February 24, 2024, the Drug Enforcement Administration (“DEA”) released a long-anticipated proposed rule that aims to permanently extend controlled substance prescribing flexibilities beyond the COVID-19 Public Health...more
2/28/2023
/ Controlled Substances ,
DEA ,
Health Care Providers ,
Healthcare ,
Healthcare Reform ,
Patient Access ,
Pharmaceutical Distribution ,
Pharmaceutical Industry ,
Prescription Drugs ,
Proposed Rules ,
Telehealth ,
Telemedicine
On July 07, 2022 the Centers for Medicare and Medicaid Services (“CMS”) released the 2023 Physician Fee Schedule (“PFS”) Proposed Rule, which proposes several significant changes to Medicare telehealth services....more
8/2/2022
/ Centers for Medicare & Medicaid Services (CMS) ,
Comment Period ,
FQHC ,
Health Care Providers ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Medicare ,
Physician Fee Schedule ,
Proposed Rules ,
Public Comment ,
Regulatory Agenda ,
Rural Health Care Program ,
Telehealth ,
Telemedicine
In November 2021, the Centers for Medicare and Medicaid Services (“CMS”) issued the Physician Fee Schedule Final Rule (“Final Rule”) which includes several telehealth policy updates that will go into effect in calendar year...more
12/21/2021
/ Centers for Medicare & Medicaid Services (CMS) ,
Coronavirus/COVID-19 ,
Health Care Providers ,
Healthcare ,
Infectious Diseases ,
Mental Health ,
Patient Access ,
Physician Fee Schedule ,
Physicians ,
Telehealth ,
Telemedicine